Clinicopathological Characteristics for NSCLC Harboring EGFR Exon 20 Insertion

被引：0
|
作者：
Morikawa, K. [1 ]
Kakinuma, K. [1 ]
Inoue, T. [1 ]
Mineshita, M. [1 ]
机构：
[1] St Marianna Univ, Sch Med, Kawasaki, Kanagawa, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
EGFR-mutant NSCLC; Exon; 20; insertion;
D O I：
10.1016/j.jtho.2019.08.1032
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.09-03
引用
收藏
页码：S496 / S496
页数：1
相关论文
共 50 条
  • [1] Response to Afatinib in a Patient with NSCLC Harboring Novel EGFR Exon 20 Insertion Mutations
    Lin, Ling
    Wu, Xiaomai
    Yan, Shuangquan
    Zhu, Yefei
    Yan, Zhengqing
    Lv, Dongqing
    Ge, Hongfei
    ONCOTARGETS AND THERAPY, 2020, 13 : 9753 - 9757
  • [2] Response to Afatinib in a Patient with NSCLC Harboring Novel EGFR Exon 20 Insertion Mutations
    Lv, D.
    Lin, L.
    Wu, X.
    Yan, S.
    Ge, H.
    Yan, Z.
    Wang, G.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S634 - S634
  • [3] Comparative Clinical Outcomes for Patients with NSCLC Harboring EGFR Exon 20 Insertion Mutations and Common EGFR Mutations
    Girard, N.
    Bazhenova, L.
    Minchom, A.
    Ou, S.
    Gadgeel, S.
    Trigo, J.
    Viteri, S.
    Li, G.
    Mahadevia, P.
    Londhe, A.
    Backenroth, D.
    Li, T.
    Bauml, J. M.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S145 - S146
  • [4] Clinicopathological Characteristics of 11 NSCLC Patients with EGFR-Exon 20 Mutations
    Lund-Iversen, Marius
    Kleinberg, Lilach
    Fjellbirkeland, Lars
    Helland, Aslaug
    Brustugun, Odd Terje
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : 1471 - 1473
  • [5] Comparative clinical outcomes for patients with advanced NSCLC harboring EGFR exon 20 insertion mutations and common EGFR mutations
    Bazhenova, Lyudmila
    Minchom, Anna
    Viteri, Santiago
    Bauml, Joshua M.
    Ou, Sai-Hong Ignatius
    Gadgeel, Shirish M.
    Manuel Trigo, Jose
    Backenroth, Daniel
    Li, Tracy
    Londhe, Anil
    Mahadevia, Parthiv
    Girard, Nicolas
    LUNG CANCER, 2021, 162 : 154 - 161
  • [6] Identification of a new insertion in exon 20 of EGFR in a woman with NSCLC
    Angela Zupa
    Giulia Vita
    Matteo Landriscina
    Luciana Possidente
    Michele Aieta
    Alfredo Tartarone
    Giuseppina Improta
    Medical Oncology, 2012, 29 : 3198 - 3201
  • [7] Identification of a new insertion in exon 20 of EGFR in a woman with NSCLC
    Zupa, Angela
    Vita, Giulia
    Landriscina, Matteo
    Possidente, Luciana
    Aieta, Michele
    Tartarone, Alfredo
    Improta, Giuseppina
    MEDICAL ONCOLOGY, 2012, 29 (05) : 3198 - 3201
  • [8] Distribution and Detectability of EGFR Exon 20 Insertion Variants in NSCLC
    Ou, Sai-Hong Ignatius
    Hong, Jin-Liern
    Christopoulos, Petros
    Lin, Huamao M.
    Vincent, Sylvie
    Churchill, Eric N.
    Soeda, Junpei
    Kazdal, Daniel
    Stenzinger, Albrecht
    Thomas, Michael
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (06) : 744 - 754
  • [9] Osimertinib (AZD9291) is effective against NSCLC cells harboring EGFR exon 20 insertion mutations
    Lee, Yusoo
    Kim, Tae Min
    Kim, Dong-Wan
    Ahn, Yong-Oon
    Kim, Soyeon
    Keam, Bhumsuk
    Kim, Miso
    Heo, Dae Seog
    CANCER RESEARCH, 2017, 77
  • [10] Antitumor activity of osimertinib in NSCLC harboring EGFR exon 20 insertions.
    Riess, Jonathan
    Floch, Nicolas
    Martin, Matthew
    Orme, Jonathon
    Staniszewska, Anna
    Menard, Ludovic
    Cuomo, Maria Emanuela
    O'Neill, Daniel
    Ward, Richard
    Finlay, Raymond
    McKerrecher, Darren
    Cheng, Mingshan
    Tang, Daniel
    Tsai, Rebekah
    Ye, Chunting
    Keck, James G.
    Gandara, David R.
    Mack, Philip C.
    Cross, Darren
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345